S&P 500   5,074.60 (-0.07%)
DOW   38,894.65 (-0.20%)
QQQ   436.58 (-0.23%)
AAPL   181.30 (-0.73%)
MSFT   407.80 (+0.08%)
META   486.74 (-0.06%)
GOOGL   136.25 (-1.89%)
AMZN   173.83 (+0.17%)
TSLA   204.54 (+2.41%)
NVDA   788.70 (+0.21%)
NIO   5.52 (-4.50%)
AMD   176.55 (-0.81%)
BABA   75.25 (-3.13%)
T   17.00 (+1.01%)
F   12.29 (+2.42%)
MU   90.09 (-1.92%)
CGC   3.48 (-1.42%)
GE   155.21 (+0.79%)
DIS   110.72 (+1.19%)
AMC   5.01 (+4.16%)
PFE   27.09 (+0.74%)
PYPL   60.65 (+0.81%)
XOM   104.32 (+0.28%)
S&P 500   5,074.60 (-0.07%)
DOW   38,894.65 (-0.20%)
QQQ   436.58 (-0.23%)
AAPL   181.30 (-0.73%)
MSFT   407.80 (+0.08%)
META   486.74 (-0.06%)
GOOGL   136.25 (-1.89%)
AMZN   173.83 (+0.17%)
TSLA   204.54 (+2.41%)
NVDA   788.70 (+0.21%)
NIO   5.52 (-4.50%)
AMD   176.55 (-0.81%)
BABA   75.25 (-3.13%)
T   17.00 (+1.01%)
F   12.29 (+2.42%)
MU   90.09 (-1.92%)
CGC   3.48 (-1.42%)
GE   155.21 (+0.79%)
DIS   110.72 (+1.19%)
AMC   5.01 (+4.16%)
PFE   27.09 (+0.74%)
PYPL   60.65 (+0.81%)
XOM   104.32 (+0.28%)
S&P 500   5,074.60 (-0.07%)
DOW   38,894.65 (-0.20%)
QQQ   436.58 (-0.23%)
AAPL   181.30 (-0.73%)
MSFT   407.80 (+0.08%)
META   486.74 (-0.06%)
GOOGL   136.25 (-1.89%)
AMZN   173.83 (+0.17%)
TSLA   204.54 (+2.41%)
NVDA   788.70 (+0.21%)
NIO   5.52 (-4.50%)
AMD   176.55 (-0.81%)
BABA   75.25 (-3.13%)
T   17.00 (+1.01%)
F   12.29 (+2.42%)
MU   90.09 (-1.92%)
CGC   3.48 (-1.42%)
GE   155.21 (+0.79%)
DIS   110.72 (+1.19%)
AMC   5.01 (+4.16%)
PFE   27.09 (+0.74%)
PYPL   60.65 (+0.81%)
XOM   104.32 (+0.28%)
S&P 500   5,074.60 (-0.07%)
DOW   38,894.65 (-0.20%)
QQQ   436.58 (-0.23%)
AAPL   181.30 (-0.73%)
MSFT   407.80 (+0.08%)
META   486.74 (-0.06%)
GOOGL   136.25 (-1.89%)
AMZN   173.83 (+0.17%)
TSLA   204.54 (+2.41%)
NVDA   788.70 (+0.21%)
NIO   5.52 (-4.50%)
AMD   176.55 (-0.81%)
BABA   75.25 (-3.13%)
T   17.00 (+1.01%)
F   12.29 (+2.42%)
MU   90.09 (-1.92%)
CGC   3.48 (-1.42%)
GE   155.21 (+0.79%)
DIS   110.72 (+1.19%)
AMC   5.01 (+4.16%)
PFE   27.09 (+0.74%)
PYPL   60.65 (+0.81%)
XOM   104.32 (+0.28%)

Day One Biopharmaceuticals (DAWN) Earnings Date, Estimates & Call Transcripts

$17.18
-0.20 (-1.15%)
(As of 11:45 AM ET)
Skip Charts & View Estimated and Actual Earnings Data

DAWN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DAWN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Day One Biopharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($0.61)($0.57)($0.59)
Q2 20243($0.60)($0.58)($0.59)
Q3 20243($0.63)($0.42)($0.50)
Q4 20243($0.63)($0.45)($0.56)
FY 202412($2.47)($2.02)($2.24)
Q1 20251($0.45)($0.45)($0.45)
Q2 20251($0.39)($0.39)($0.39)
Q3 20251($0.33)($0.33)($0.33)
Q4 20251($0.24)($0.24)($0.24)
FY 20254($1.41)($1.41)($1.41)

DAWN Earnings Date and Information

Day One Biopharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 6th, 2024 based off prior year's report dates.

Day One Biopharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/6/2024
Estimated)
------- 
11/6/2023Q3 2023($0.60)($0.54)+$0.06($0.54)--
8/7/2023Q2 2023($0.60)($0.61)($0.01)($0.61)--
5/1/2023Q1 2023($0.59)($0.59)-($0.59)--
3/6/2023Q4 2022($0.57)($0.56)+$0.01($0.56)--
11/7/2022Q3 2022($0.53)($0.53)-($0.53)--
8/4/2022Q2 2022($0.49)($0.60)($0.11)($0.60)--
5/12/2022Q1 2022($0.39)($0.48)($0.09)($0.48)--    
3/7/2022Q4 2021($0.35)($0.36)($0.01)---
11/7/2021Q3 2021($0.28)($0.33)($0.05)($0.33)--
8/9/2021Q2 2021($0.32)($5.04)($4.72)$3.78--












Day One Biopharmaceuticals Earnings - Frequently Asked Questions

When is Day One Biopharmaceuticals's earnings date?

Day One Biopharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 6th, 2024 based off last year's report dates. Learn more on DAWN's earnings history.

How much profit does Day One Biopharmaceuticals generate each year?

Day One Biopharmaceuticals (NASDAQ:DAWN) has a recorded net income of -$142.18 million. DAWN has generated -$2.38 earnings per share over the last four quarters.

What is Day One Biopharmaceuticals's EPS forecast for next year?

Day One Biopharmaceuticals's earnings are expected to grow from ($2.31) per share to ($1.63) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:DAWN) was last updated on 2/28/2024 by MarketBeat.com Staff